Outcomes | Midodrine group | Control Group | OR (CI) | p value |
---|---|---|---|---|
Days free from ICU at 30 days | 25.8 [23.7–27.1] | 27.2 [25.9–28] | N/A | 0.002* |
In-hospital mortality | 10 (13.5%) | 1 (1.4%) | 12.5 (1.5–105.2)* | 0.036* |
ICU readmission | 6 (8.1%) | 2 (2.7%) | 3.1 (0.8–19.2)* | 0.103* |
Total time on IV vasopressors (h) | 63 [40–86.5] | 44 [26–66] | N/A | 0.052* |
ICU length of stay | 99 [68–146] | 68 [48–99] | N/A | 0.001 |
Severe acute kidney injury | 11 (14.9%) | 10 (13.5%) | 1.12 (0.4–2.8) | 0.462 |